Informações:
Falhas:
ID
23568
Descrição
Quality Of Life While Receiving Faslodex; ODM derived from: https://clinicaltrials.gov/show/NCT00643513
Link
https://clinicaltrials.gov/show/NCT00643513
Palavras-chave
Versões (1)
- 09/07/2017 09/07/2017 -
Transferido a
9 de julho de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Breast Cancer NCT00643513
Eligibility Breast Cancer NCT00643513
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00643513
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Breast Carcinoma
Item
histologic and/or cytological proven breast cancer.
boolean
C0678222 (UMLS CUI [1])
Secondary malignant neoplasm of female breast | Postmenopausal state | Primary tumor Disease length
Item
patients with metastases of breast cancer ± postmenopausal primary tumor ≥12 months.
boolean
C0346993 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0677930 (UMLS CUI [3,1])
C0872146 (UMLS CUI [3,2])
C0232970 (UMLS CUI [2])
C0677930 (UMLS CUI [3,1])
C0872146 (UMLS CUI [3,2])
Estrogen receptor positive | Progesterone receptor positive | Hormone Receptor Unknown | Operative Surgical Procedures | Neoplasm Metastasis | Hormone sensitive malignancy status
Item
positive oestrogen receptors (er+), positive progesterone receptors (pgr+) or unknown hormonal receptors (if duration between surgery and metastasis occurring is not less 2 years) which are indirect confirmation of hormone sensitive tumor.
boolean
C0279754 (UMLS CUI [1])
C0279759 (UMLS CUI [2])
C0019929 (UMLS CUI [3,1])
C0439673 (UMLS CUI [3,2])
C0543467 (UMLS CUI [4])
C0027627 (UMLS CUI [5])
C4270758 (UMLS CUI [6])
C0279759 (UMLS CUI [2])
C0019929 (UMLS CUI [3,1])
C0439673 (UMLS CUI [3,2])
C0543467 (UMLS CUI [4])
C0027627 (UMLS CUI [5])
C4270758 (UMLS CUI [6])
ECOG performance status
Item
ecog performance status of ≤ 2
boolean
C1520224 (UMLS CUI [1])
Study Subject Participation Status Willing
Item
patient willingness to take part in the programm
boolean
C2348568 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,2])
Life Expectancy
Item
life expectancy of more than 6 months.
boolean
C0023671 (UMLS CUI [1])
Questionnaire Completion Ability
Item
patient ability to complete a questionnaire.
boolean
C0034394 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Medical contraindication Faslodex
Item
contraindications for faslodex therapy
boolean
C1301624 (UMLS CUI [1,1])
C0701491 (UMLS CUI [1,2])
C0701491 (UMLS CUI [1,2])
Cancer treatment | Chemotherapy | Hormone Therapy | Investigational New Drugs | Therapeutic radiology procedure | Measurable Disease | Evaluable Disease
Item
other anticancer therapy (chemotherapy, hormonal therapy with other drugs, radiotherapy), except for radiotherapy of sites which are not only measurable or evaluable manifestation of disease.
boolean
C0920425 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C0013230 (UMLS CUI [4])
C1522449 (UMLS CUI [5])
C1513041 (UMLS CUI [6])
C1516986 (UMLS CUI [7])
C0392920 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C0013230 (UMLS CUI [4])
C1522449 (UMLS CUI [5])
C1513041 (UMLS CUI [6])
C1516986 (UMLS CUI [7])